Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 5
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events.
Mannucci E, Gallo M, Giaccari A, Candido R, Pintaudi B, Targher G, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Diabetes Obes Metab. 2023 Feb;25(2):444-453. doi: 10.1111/dom.14888. Epub 2022 Oct 24. Diabetes Obes Metab. 2023. PMID: 36205446
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials.
Mannucci E, Nreu B, Montereggi C, Ragghianti B, Gallo M, Giaccari A, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2745-2755. doi: 10.1016/j.numecd.2021.06.002. Epub 2021 Jul 5. Nutr Metab Cardiovasc Dis. 2021. PMID: 34364771
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
Mannucci E, Giaccari A, Gallo M, Targher G, Pintaudi B, Candido R, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):529-536. doi: 10.1016/j.numecd.2021.12.006. Epub 2021 Dec 10. Nutr Metab Cardiovasc Dis. 2022. PMID: 35144855
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
Mannucci E, Targher G, Nreu B, Pintaudi B, Candido R, Giaccari A, Gallo M, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1353-1360. doi: 10.1016/j.numecd.2022.03.007. Epub 2022 Mar 15. Nutr Metab Cardiovasc Dis. 2022. PMID: 35422359
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials.
Mannucci E, Gallo M, Pintaudi B, Targher G, Candido R, Giaccari A, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2022 Feb;32(2):511-514. doi: 10.1016/j.numecd.2021.10.010. Epub 2021 Nov 1. Nutr Metab Cardiovasc Dis. 2022. PMID: 34893404